These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


459 related items for PubMed ID: 18783080

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M, Gaspardone A, Fragasso G, Ajello S, Gioffrè G, Iamele M, Iani C, Margonato A.
    Am J Cardiol; 2009 Aug 01; 104(3):434-9. PubMed ID: 19616680
    [Abstract] [Full Text] [Related]

  • 4. Patent foramen ovale--assessment and treatment.
    Irwin B, Ray S.
    Cardiovasc Ther; 2012 Jun 01; 30(3):e128-35. PubMed ID: 21883994
    [Abstract] [Full Text] [Related]

  • 5. Feasibility of patent foramen ovale closure with no-device left behind: first-in-man percutaneous suture closure.
    Ruiz CE, Kipshidze N, Chiam PT, Gogorishvili I.
    Catheter Cardiovasc Interv; 2008 Jun 01; 71(7):921-6. PubMed ID: 18412251
    [Abstract] [Full Text] [Related]

  • 6. Migraine headache relief after transcatheter closure of patent foramen ovale.
    Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, Diehl L, Aurora S, Gray WA.
    J Am Coll Cardiol; 2005 Feb 15; 45(4):493-5. PubMed ID: 15708692
    [Abstract] [Full Text] [Related]

  • 7. Patent foramen ovale and cerebrovascular diseases.
    Desai AJ, Fuller CJ, Jesurum JT, Reisman M.
    Nat Clin Pract Cardiovasc Med; 2006 Aug 15; 3(8):446-55. PubMed ID: 16874357
    [Abstract] [Full Text] [Related]

  • 8. Patent foramen ovale: clinical manifestations and treatment.
    Kedia G, Tobis J, Lee MS.
    Rev Cardiovasc Med; 2008 Aug 15; 9(3):168-73. PubMed ID: 18953276
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke.
    Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N.
    Catheter Cardiovasc Interv; 2006 Nov 15; 68(5):741-6. PubMed ID: 17039525
    [Abstract] [Full Text] [Related]

  • 15. Migraine and patent foramen ovale: connecting flight or one-way ticket?
    Rigatelli G.
    Expert Rev Neurother; 2008 Sep 15; 8(9):1331-7. PubMed ID: 18759545
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patent foramen ovale: pathophysiology and therapeutic options in symptomatic patients.
    Wahl A, Windecker S, Meier B.
    Minerva Cardioangiol; 2001 Dec 15; 49(6):403-11. PubMed ID: 11733736
    [Abstract] [Full Text] [Related]

  • 18. Migraine, stroke and patent foramen ovale: a dangerous trio?
    Butera G, Agostoni E, Biondi-Zoccai G, Bresolin N, Fumagalli L, Chessa M, Gallanti A, Scacciatela P, Carminati M.
    J Cardiovasc Med (Hagerstown); 2008 Mar 15; 9(3):233-8. PubMed ID: 18301138
    [Abstract] [Full Text] [Related]

  • 19. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA.
    Am J Cardiol; 2008 May 15; 101(10):1487-92. PubMed ID: 18471463
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.